ABCG2 and diffuse large B-cell lymphoma: In this sense, it is evident that the Hh pathway promotes the expression of ABCG2 as GLI-1 is capable of binding to the promoter region of ABCG2, thus promoting resistance to therapy in diffuse large B-cell lymphoma [124].